Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

Inhaled bronchodilators (alone or in combination) are the cornerstone of treatment for
symptomatic patients with COPD, either as initial/first-line treatment or for second …

Purpose Role of triple therapy in chronic obstructive pulmonary disease (COPD)
management is supported by growing evidence, but consensus is lacking on various …

Chronic obstructive pulmonary disease (COPD) is one of the major causes of disability and
death. Maintenance use of inhaled bronchodilator (s) is the cornerstone of COPD …

Purpose This study aimed to describe the real-world treatment of German incident COPD
patients, compare that treatment with clinical guidelines, and provide insight into disease …

Introduction As of today, there is still a need to determine which COPD patients may benefit
from ICS therapy, whether ICSs are useful in COPD patients without chronic bronchitis, and …

The use of inhaled corticosteroids (ICS) for the maintenance of bronchodilator treatment in
patients with chronic obstructive pulmonary disease (COPD) is controversial. While some …

COPD is a major healthcare problem and cause of mortality worldwide. COPD patients at
increased mortality risk are those who are more symptomatic, have lower lung function and …

Background A decreasing use of inhaled corticosteroids (ICS) in patients with a hospital-
registered diagnosis of chronic obstructive pulmonary disease (COPD) has recently been …

Introduction Long-acting muscarinic receptor antagonist (LAMA)/β2-agonist (LABA)
combinations represent a significant improvement in the treatment of chronic obstructive …